All AbMole products are for research use only, cannot be used for human consumption.
Blu-945 is a potent inhibitor of selective epidermal growth factor receptor (EGFR). EGFR is a member of the erbB receptor family, which includes receptors for transmembrane protein tyrosine kinases. Blu-945 effectively inhibits EGFR with L858R and/or exon 19 deletion mutations, T790M mutations and C797S mutations. Blu-945 contributes to effective administration and reduces egFR-mediated targeted toxicity. Blu-945 has the potential to study cancer diseases.
| Molecular Weight | 556.7 |
| Formula | C28H37FN6O3S |
| CAS Number | 2660250-10-0 |
| Solubility (25°C) | DMSO 90 mg/mL |
| Storage | 4°C, protect from light |
| Related EGFR/HER2 Products |
|---|
| Sevabertinib
Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity. |
| BPIQ-I
BPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor.. |
| HKI-357
HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM, respectively. |
| SJF-1528
SJF-1528 is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutated EGFR in HeLa cells. |
| CH7233163
CH7233163 is a noncovalent ATP-competitive inhibitor for EGFR-Del19/T790M/C797S. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
